Back
Rivian Automotive Vs. Kymera Therapeutics Industry Stock Comparison
Buy
61
RIVN
Rivian Automotive
Last Price:
13.53
Seasonality Move:
-19.44%
Buy
67
KYMR
Kymera Therapeutics
Last Price:
44.40
Seasonality Move:
-6.51%
Buy
61
Rivian Automotive (RIVN)
is a Buy
Is Rivian Automotive a Buy, Sell or Hold?
- The current Rivian Automotive [RIVN] share price is $13.21. The Score for RIVN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- RIVN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $43.80. The Score for KYMR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RIVN Stock Price Chart
What is Rivian Automotive's stock price today?
-
The Rivian Automotive share price today is $13.21
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RIVN is experiencing slight selling pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $43.80
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.
RIVN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.46 | Sell |
Relative Strength Index (14 RSI): | 39.14 | Sell |
Chaikin Money Flow: | -17439024 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.01 - 17.01) | Sell |
Bollinger Bands (100): | (9.46 - 14.92) | Buy |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.08 | Buy |
Relative Strength Index (14 RSI): | 56.59 | Buy |
Chaikin Money Flow: | -25430 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.48 - 45.3) | Buy |
Bollinger Bands (100): | (32.4 - 41.52) | Buy |
RIVN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.7 | Sell |
20-day SMA: | 15.07 | Sell |
50-day SMA: | 14.35 | Sell |
200-day SMA: | 14.28 | Sell |
8-day EMA: | 13.8 | Sell |
20-day EMA: | 14.52 | Sell |
50-day EMA: | 14.19 | Sell |
200-day EMA: | 14.73 | Sell |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.47 | Buy |
20-day SMA: | 42.87 | Buy |
50-day SMA: | 38.23 | Buy |
200-day SMA: | 33.07 | Buy |
8-day EMA: | 42.93 | Buy |
20-day EMA: | 42.2 | Buy |
50-day EMA: | 39.81 | Buy |
200-day EMA: | 34.21 | Buy |
Rivian Automotive Earnings Growth & RIVN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.13 per share, an increase this year of $0.97 per share, and an increase next year of $1.17 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.38 per share.
Rivian Automotive Technical Analysis
Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 9 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 9 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |